U.S. Markets closed

Pfizer to Merge Off-Patent Drug Business With Mylan: WSJ

Pfizer plans to divest its off-patent drug business and combine it with Mylan. The newly formed company will put Mylan's EpiPen and Pfizer's Viagra under one umbrella. Yahoo Finance's Akiko Fujita and Scott Gamm discuss.